Medisch Kabinet Dr Lieven De Norre, huisarts
0545.990.729 · rovalta.com · 28/09/2026
NORMAL SITUATION
Medisch Kabinet Dr Lieven De Norre, huisarts
Company — Normal situation.
Financial year 2023 · Closed on 31/12/2023
Net result28,2 k €-60,0 %over 1 year
Gross margin48,8 k €-48,4 %over 1 year
Equity384 k €+7,9 %over 1 year
Overview
Identity
Source · BCE/KBOMedisch Kabinet Dr Lieven De Norre, huisarts is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0545.990.729
- Legal form
- Private company with limited liability
- Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2023
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 10 filingsTrend over 10 financial years
| 2023 | 2022 | 2021 | 2020 | 2019 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 48,8 k € | -48.4% | 94,7 k € | -7.2% | 102 k € | +21.9% | 83,7 k € | +7.7% | 77,7 k € |
| EBITDA | 43 k € | -54.2% | 94 k € | -7.0% | 101,1 k € | +22.1% | 82,8 k € | +7.2% | 77,2 k € |
| Operating result | 43 k € | -52.8% | 91,2 k € | -9.8% | 101,1 k € | +22.1% | 82,8 k € | +12.3% | 73,7 k € |
| Net result | 28,2 k € | -60.0% | 70,6 k € | -3.1% | 72,9 k € | +22.4% | 59,6 k € | +11.3% | 53,6 k € |
| Balance sheet | |||||||||
| Equity | 384 k € | +7.9% | 355,8 k € | +24.8% | 285,1 k € | +34.4% | 212,2 k € | +39.0% | 152,6 k € |
| Total assets | 393,5 k € | +10.4% | 356,4 k € | +21.8% | 292,6 k € | +26.2% | 232 k € | +41.5% | 163,9 k € |
| Cash | 281,2 k € | +88.9% | 148,8 k € | +0.9% | 147,5 k € | +47.5% | 100 k € | -37.1% | 158,8 k € |
| Debts | 3,2 k € | +407% | 638,5 € | -91.5% | 7,5 k € | -62.1% | 19,7 k € | +90.0% | 10,4 k € |
Board of directors
Source · NBB, accounts to 31/12/20231 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Lieven De Norre | DirectorManagerended |
Financials
Full financial information
Source · NBB| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 |
| Closing of the financial year | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 03/06/2024 | 28/07/2023 | 31/08/2022 | 29/10/2021 | 07/10/2020 | 31/08/2019 |
| General meeting | 12/05/2024 | 13/06/2023 | 14/06/2022 | 08/06/2021 | 09/06/2020 | 11/06/2019 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 10 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2023 | 12/05/2024 | 03/06/2024 | Dutch | |
| Micro model | 31/12/2022 | 13/06/2023 | 28/07/2023 | Dutch | |
| Micro model | 31/12/2021 | 14/06/2022 | 31/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 08/06/2021 | 29/10/2021 | Dutch | |
| Micro model | 31/12/2019 | 09/06/2020 | 07/10/2020 | Dutch | |
| Micro model | 31/12/2018 | 11/06/2019 | 31/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 21/09/2018 | 26/09/2018 | Dutch | |
| Abridged model | 31/12/2016 | 09/06/2017 | 31/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 14/06/2016 | 31/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 01/01/2015 | 31/08/2015 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20231 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Lieven De Norre | DirectorManagerended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Name
Registered office
Annual accounts
Filings10 filings
2014201520162017201820192020202120222023202420252026
Medisch Kabinet Dr Lieven De Norre, huisarts
Gemeentestraat(LIN) 9, 3210 Lubbeek
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Gemeentestraat(LIN) 9, 3210 Lubbeek | accounts 2021 → 2023 | Accounts 2023 · 2024-00105639 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Medisch Kabinet Dr Lieven De Norre, huisarts | accounts 2021 → 2023 | Accounts 2023 · 2024-00105639 |
Events
- 2023Annual accounts 202328,2 k €↓
- 2022Annual accounts 202270,6 k €↓
- 2021Annual accounts 202172,9 k €↑
- 2020Annual accounts 202059,6 k €↑
- 2019Annual accounts 201953,6 k €↑
- 2018Annual accounts 201848,1 k €↓
- 2017Annual accounts 201761,2 k €↑
- 2016Annual accounts 201654,2 k €↑
- 2015Annual accounts 201537,3 k €↓
- 2014Annual accounts 201450,5 k €